Completed
Phase 3
Age: 65Years +
FEMALE
Healthy Volunteers
ID00000176
Alzheimers Disease Prevention Trial. A Multi-center, Randomized, Double-blind Placebo Controlled Trial of Estrogens to Prevent Alzheimers Disease and Loss of Memory in Women.
Led by National Institute on Aging (NIA) · Updated on 2010-11-05
N/A
Participants Needed
22
Research Sites
N/A
Total Duration
On this page
AI-Summary
What this Trial Is About
This is a three-year study to determine if estrogens can prevent memory loss and Alzheimer's disease in women with a family history of Alzheimer's disease.
CONDITIONS
Brief Title
Alzheimer's Disease Prevention Trial
Who Can Participate
Age: 65Years +
FEMALE
Healthy Volunteers
Eligibility Criteria
Inclusion Criteria:
- Healthy women 65 or older with a family history of memory problems not currently on estrogen.
Exclusion Criteria:
- Significant neurological impairment
- Current estrogen use
- History of breast cancer
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here